Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
66,673,984
-
Share change
-
-2,435,391
-
Total reported value
-
$628,735,103
-
Put/Call ratio
-
401%
-
Price per share
-
$9.43
-
Number of holders
-
107
-
Value change
-
-$40,893,817
-
Number of buys
-
51
-
Number of sells
-
63
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q3 2021
As of 30 Sep 2021 Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 66,673,984 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, Sarissa Capital Management LP, Bellevue Group AG, STATE STREET CORP, Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, Rock Springs Capital Management LP, and ORBIMED ADVISORS LLC.
This table shows 107 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.